JMPWA
ARRY

JP Morgan Private Wealth Advisors’s Array Biopharma Inc ARRY Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,050
Closed -$286K – 1547
2018
Q4 		$286K Buy
+20,050
New +$304K ﹤0.01% 1192
2015
Q3 		– Sell
-11,290
Closed -$81K – 1176
2015
Q2 		$81K Hold
11,290
– – ﹤0.01% 1019
2015
Q1 		$83K Hold
11,290
– – ﹤0.01% 1097
2014
Q4 		$53K Buy
11,290
+1,080
+11% +$4.27K ﹤0.01% 1067
2014
Q3 		$36K Buy
+10,210
New +$40.2K ﹤0.01% 1065

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ARRY Position: Q1 2019 in Review

JP Morgan Private Wealth Advisors sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 20,050 shares — an estimated $286K sold.

JP Morgan Private Wealth Advisors first reported a position in ARRY in Q3 2014 and held it in 5 quarters. The position peaked at $286K in Q4 2018. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • JP Morgan Private Wealth Advisors reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 20,050 Array Biopharma Inc shares in Q1 2019, an estimated $286K.
  • JP Morgan Private Wealth Advisors first reported a position in Array Biopharma Inc in Q3 2014 and held it in 5 quarters.
  • JP Morgan Private Wealth Advisors's Array Biopharma Inc position peaked at $286K in Q4 2018.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2019, filed 30 Apr 2019.